webinar register page

Webinar banner
Translational and Clinical Pharmacology Considerations in the Development of Immune-Oncology Drugs
The presentation will highlight the hallmarks of immuno-oncology drug development and expand on pharmacometrics, clinical pharmacology and statistical strategies to optimize clinical trial design and development of immune-oncology drugs. This will be the first webinar of a three-part series on immune-oncology drug development. Highlights of this session will include:
• Fundamental biology underpinnings and trajectory of immune-oncology drug development and how this differs from the standard clinical development paradigm in oncology.
• Role and impact of clinical pharmacology aspects to support immune-oncology drug development for monotherapy and combination.
• Modeling and simulation strategies and clinical trial designs for early development and pivotal trials.

Aug 28, 2020 02:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Lisa Infelise.